These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1114 related articles for article (PubMed ID: 33598716)

  • 1. Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection, May-July 2020.
    Lee JT; Hesse EM; Paulin HN; Datta D; Katz LS; Talwar A; Chang G; Galang RR; Harcourt JL; Tamin A; Thornburg NJ; Wong KK; Stevens V; Kim K; Tong S; Zhou B; Queen K; Drobeniuc J; Folster JM; Sexton DJ; Ramachandran S; Browne H; Iskander J; Mitruka K
    Clin Infect Dis; 2021 Dec; 73(12):2217-2225. PubMed ID: 33598716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study.
    Ao Z; Li Y; Wei J; Jiang J; Wang X; Zhang P; Liu Y; Yu H; Zhu L; Wang X; Hu Q; Duan J; Hu W; Zhang X; Wu G; Guo S
    Clin Exp Med; 2021 Aug; 21(3):361-367. PubMed ID: 33543353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019.
    Lee JS; Kim SY; Kim TS; Hong KH; Ryoo NH; Lee J; Park JH; Cho SI; Kim MJ; Kim YG; Kim B; Shin HS; Oh HS; Seo MS; Gwon TR; Kim Y; Park JS; Chin BS; Park WB; Park SS; Seong MW
    Clin Infect Dis; 2021 Nov; 73(9):e3002-e3008. PubMed ID: 33219681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.
    Abu-Raddad LJ; Chemaitelly H; Malek JA; Ahmed AA; Mohamoud YA; Younuskunju S; Ayoub HH; Al Kanaani Z; Al Khal A; Al Kuwari E; Butt AA; Coyle P; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul Rahim HF; Yassine HM; Al Kuwari MG; Al Romaihi HE; Al-Thani MH; Bertollini R
    Clin Infect Dis; 2021 Oct; 73(7):e1830-e1840. PubMed ID: 33315061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of potential COVID-19 recurrence in patients with late repeat positive SARS-CoV-2 testing.
    Peltan ID; Beesley SJ; Webb BJ; Lopansri BK; Sinclair W; Jacobs JR; Brown SM
    PLoS One; 2021; 16(5):e0251214. PubMed ID: 33945583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19.
    Song KH; Kim DM; Lee H; Ham SY; Oh SM; Jeong H; Jung J; Kang CK; Park JY; Kang YM; Kim JY; Park JS; Park KU; Kim ES; Kim HB
    Korean J Intern Med; 2021 Jan; 36(1):11-14. PubMed ID: 32972123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Characterization of COVID-19 Patients with Repeatedly Positive SARS-CoV-2 Tests Using a Large U.S. Electronic Health Record Database.
    Dong X; Zhou Y; Shu XO; Bernstam EV; Stern R; Aronoff DM; Xu H; Lipworth L
    Microbiol Spectr; 2021 Sep; 9(1):e0032721. PubMed ID: 34406805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction Testing.
    Shragai T; Smith-Jeffcoat SE; Koh M; Schechter MC; Rebolledo PA; Kasinathan V; Wang Y; Hoffman A; Miller H; Tejada-Strop A; Jain S; Tamin A; Harcourt JL; Thornburg NJ; Wong P; Medrzycki M; Folster JM; Semenova V; Steward-Clark E; Drobenuic J; Biedron C; Stewart RJ; da Silva J; Kirking HL; Tate JE;
    J Infect Dis; 2022 Jan; 225(2):229-237. PubMed ID: 34216468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing.
    To KK; Hung IF; Ip JD; Chu AW; Chan WM; Tam AR; Fong CH; Yuan S; Tsoi HW; Ng AC; Lee LL; Wan P; Tso EY; To WK; Tsang DN; Chan KH; Huang JD; Kok KH; Cheng VC; Yuen KY
    Clin Infect Dis; 2021 Nov; 73(9):e2946-e2951. PubMed ID: 32840608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between Antibody Levels and SARS-Cov-2 Reinfection.
    Islamoglu MS; Cengiz M; Uysal BB; Ikitimur H; Ozdemir Z; Karamehmetoglu A; Akbulut AE; Bakdur AN; Ozdemir A; Kayıkcıoglu H; Ozdemir H; Uces R; Ersoy S; Yavuzer S
    Ann Clin Lab Sci; 2021 Nov; 51(6):750-755. PubMed ID: 34921027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection.
    Murillo-Zamora E; Mendoza-Cano O; Delgado-Enciso I; Hernandez-Suarez CM
    Public Health; 2021 Apr; 193():113-115. PubMed ID: 33774512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
    Petrie JG; Bazzi LA; McDermott AB; Follmann D; Esposito D; Hatcher C; Mateja A; Narpala SR; O'Connell SE; Martin ET; Monto AS
    J Infect Dis; 2021 Jul; 224(1):49-59. PubMed ID: 33755731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of SARS-CoV-2 symptomatic reinfection in four healthcare professionals from the same hospital despite the presence of antibodies.
    Gargouri S; Souissi A; Abid N; Chtourou A; Feki-Berrajah L; Karray R; Kossentini H; Ben Ayed I; Abdelmoula F; Chakroun O; Nasri A; Hammami A; Rekik N; Masmoudi S; Karray-Hakim H; Rebai A
    Int J Infect Dis; 2022 Apr; 117():146-154. PubMed ID: 35017107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study.
    Turbett SE; Tomkins-Tinch CH; Anahtar MN; Dugdale CM; Hyle EP; Shenoy ES; Shaw B; Egbuonu K; Bowman KA; Zachary KC; Adams GC; Hooper DC; Ryan ET; LaRocque RC; Bassett IV; Triant VA; Siddle KJ; Rosenberg E; Sabeti PC; Schaffner SF; MacInnis BL; Lemieux JE; Charles RC
    Clin Infect Dis; 2023 Mar; 76(5):850-860. PubMed ID: 36268576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentials of SARS-CoV-2 Viral RNA Re-positivity in Discharged COVID-19 Patients.
    Xia J; Zeng Y; Tan Z; Chen T; Hu W; Shuai S; Cao D; Zeng X
    AIDS Rev; 2021 Jun; 23(3):153-163. PubMed ID: 34082440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reinfections from SARS-CoV-2: A Retrospective Study from the Gyncentrum Genetic Laboratory in Sosnowiec, Poland, April 2020 to July 2022.
    Morawiec E; Bednarska-Czerwińska A; Pudełko A; Zmarzły N; Rojczyk E; Madej K; Sobański D; Staszkiewicz R; Ossowski P; Boroń-Kaczmarska A; Zapletal-Pudełko K; Boroń D; Grabarek BO
    Med Sci Monit; 2023 Mar; 29():e939452. PubMed ID: 36964642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sinonasal manifestations and dynamic profile of RT-PCR results for SARS-CoV-2 in COVID-19 patients.
    Jia X; Shao S; Ren H; Xu Y; Zhao J; Zhao Y; Wang Y; Bao S; Yan J; Wang X; Zhang L
    Ann Palliat Med; 2021 Apr; 10(4):4174-4183. PubMed ID: 33832289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic Characteristics Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen-Based Test Results, Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) Cycle Threshold Values, Subgenomic RNA, and Viral Culture Results From University Testing.
    Ford L; Lee C; Pray IW; Cole D; Bigouette JP; Abedi GR; Bushman D; Delahoy MJ; Currie DW; Cherney B; Kirby MK; Fajardo GC; Caudill M; Langolf K; Kahrs J; Zochert T; Kelly P; Pitts C; Lim A; Aulik N; Tamin A; Harcourt JL; Queen K; Zhang J; Whitaker B; Browne H; Medrzycki M; Shewmaker PL; Bonenfant G; Zhou B; Folster JM; Bankamp B; Bowen MD; Thornburg NJ; Goffard K; Limbago B; Bateman A; Tate JE; Gieryn D; Kirking HL; Westergaard RP; Killerby ME;
    Clin Infect Dis; 2021 Sep; 73(6):e1348-e1355. PubMed ID: 33846714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 reinfection and COVID-19 severity.
    Nguyen NN; Houhamdi L; Hoang VT; Delerce J; Delorme L; Colson P; Brouqui P; Fournier PE; Raoult D; Gautret P
    Emerg Microbes Infect; 2022 Dec; 11(1):894-901. PubMed ID: 35264078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 48-Year-Old Immunocompetent Female Resident of Southern Florida with Confirmed Reinfection with P.1 (Gamma) Variant of SARS-CoV-2.
    Kim M; Poon KK; Miller N; Rubio-Gomez H
    Am J Case Rep; 2022 Jan; 23():e935329. PubMed ID: 35041639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.